Trading Summary - April 29. More excellent progress

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
243
Trading Summary - April 29.

More excellent progress today for $EVSV as covered in detail in the contemporaneous earlier posts.

The main points were:

- Gapped up to .1400 at the open with a 3.5K buy.

- With most top traders busy on the other main picks on my Watch List - $SKDI and $VYST in particular - momentum was not maintained early on.

- The usual modus operandi from the iHub basher / scammers - as seen for the last 15.5 months - then kicked in - with artificially low walked down asks and occasional insignificant paint downs trying to dupe people to trade on the bid accompanied by their usual complete nonsense on the now completely marginalized forum - the level of which was ramped up - but with no significant effect.

- Despite multiple attempts to walk the ask down to the levels recorded contemporaneously - none were successful in duping anyone to sell any significant amount.

- Again, when one ventured too low he got taken out by me - just as I took out the 50K at .1210 yesterday.

- Now that there is more continual interest and comment in the larger of the 2 x Whale Team rooms (1,371 members) - and more people are learning the art of the "hail mary" buy suitably sized and set at a price a number of points above self-evident artificially low walked down ask points from shorts / manipulators - that I have been teaching people to use on $SKDI and $APRU - we started to see a few more today on $EVSV today as recorded contemporaneously.

- Each time there was a hail mary buy - or indeed just a low ask getting started - a number of asks to the upside were cancelled as the scammers didn't want to loose too many of their cheap shares bought in the .2000 > .1200 range prior to the move to .3 / .5 (for starters).

- The last hail mary buy of the day got the .1600 up and subsequently these were started.

- Seconds before the close, a paint down of 100 shares was intercepted by an invisible bid at .1405.

Again, for those able to watch all day, there was ample opportunity to buy another 15K > 50K at bargain prices but the big difference was they all had to hit the ask to do it.

With the top several traders of $EVSV now willing to buy more on the ask to deny bidders filling and make them chase, people who want to add will have to up their game - especially now it is know from today's Twitter update that multiple updates will be coming soon.

50K bought by .2000 is worth a profit of $40,950 at $1 or $20,000 at .5

Each 10K bought by .2000 is worth a profit of $18,000 at $2.

Overall, 192,897 shares were traded today - mostly on the ask - almost all in the .1335 > .1600 range - compared to the .1200 > .1600 range yesterday.

Several traders were outbidding each other all day at multiple visible levels and invisible levels as covered in the contemporaneous earlier reports but had little success compared to ask buyers.

Remember, you don't have to get the bottom price. Those that have a large inventory of shares will always do better because you never know when a stock will get run up leaving those that only bid chasing.

The Unrestricted O/S - all that matters for current trading - is still only 3M so the stock can move very quickly - especially when large enough "hail mary" buys set at higher prices than walked down asks get the ball rolling.

Remember, on December 17, 2017, 114K shares all bought on the ask in quick succession - too fast for the scammers to attempt further hold back attempts after their left up efforts were all taken out - moved the price from .2400 > .4980. That is the sort of action we want to see ahead.

otcmarkets.com now shows that a promotion campaign will be starting and we now know that there will be multiple PRs / updates ahead.

Ahead we can expect updates soon on some / all of the following:

- Sales of the first hemp distillate from the 2019 crop.

- Hemp planting at the 1st and 2nd WI farm sites..

- Hemp planting at the first site in FL.

- Start up of medical marijuana growing in MI.

- Increased revenue for the Pest Control Division for COVID-19 sterilization of facilities.

- 2019 Annual Report.

The latest DD / Rolling Brief - updated on April 26 - is here:

https://investorshangout.com/post/view?id=5748003

Alerts on future updates / trading will be in the following order:

Here !

Twitter

Telegram Whale Team

Slack Whale Team

PSG VIP

iHub Whale Team

iHub $EVSV [only when already running up]

Warning ! Anyone who is seen posting nonsense on iHub on any on the thinly traded stocks I'm a shareholder in - especially when small paint downs are also seen along with undercut asks - can expect to have their user ID passed to the SEC which has now started to take action against those using the exact modus operandi I have detected and commented on for the past 2 years:

https://www.sec.gov/news/press-release/2019-216




Enviro-Serv, Inc. (EVSV) Stock Research Links

EVSV Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 34

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 39

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 31

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 45

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 41

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Celebrating Green Leaders: 2024 IGIHOF Induction Ceremony Details

Updated Category News Views 276

Celebrating the Newest Inductees into the Green Industry The International Green Industry Hall of Fame (IGIHOF) is gearing up for its annual induction ceremony, where it will honor nine remarkable individuals and organizations dedicated to advancing ecological sustainability. This year, the event will take place within the environment of innovative learning at the...

Continue Reading
Governor Advocates for Controlled Substances Decriminalization

Updated Category News Views 48

Governor Advocates for Controlled Substances Decriminalization Puerto Rico’s Governor Pedro Pierluisi Urrutia has made a compelling argument for decriminalizing the consumption of all controlled substances. His stance primarily addresses the pressing fentanyl crisis affecting communities across the island. Governor Pierluisi highlighted, "I have said since the 90s that...

Continue Reading
Odyssey Marine Exploration: Navigating Stock Market Challenges

Updated Category News Views 221

Recent Trends in Odyssey Marine Exploration Stock Odyssey Marine Exploration, Inc. (NASDAQ: OMEX) has seen its stock price fluctuate significantly in recent times. After an arbitration award involving the company and the United Mexican States was announced, the stock experienced a sharp decline, which has sparked concerns about its future path. Decoding the Arbitration...

Continue Reading
Decent Holding Inc. Unveils US$8 Million Offering for Growth

Updated Category News Views 101

Decent Holding Inc. Announced Its New Offering In a significant move within the wastewater treatment sector, Decent Holding Inc. (NASDAQ: DXST) shared exciting news about their latest financing initiative. The company has introduced a registered offering amounting to US$8 million. This offering involves 13,333,333 Class A ordinary shares priced at US$0.60 each, along with...

Continue Reading
Nexxen Strengthens Data Strategies with Eric Solomon's Leadership

Updated Category News Views 208

Nexxen Appoints Eric Solomon to Drive Data Strategy In a significant move for the advertising technology landscape, Nexxen (NASDAQ: NEXN) has welcomed Eric Solomon as its new Senior Vice President for Product – Data. This appointment underscores Nexxen's dedication to a data-driven approach that aims to enhance growth and success for advertisers and media companies...

Continue Reading